Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Care > Global Metabolic Disorders Treatment Market Research Report 2023

Global Metabolic Disorders Treatment Market Research Report 2023

Industry: Medical Care

Published: 2023-07-25

Pages: 86 Pages

Report ld: 500496

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc.

According to QYResearch’s new survey, global Metabolic Disorders Treatment market is projected to reach US$ 160970 million in 2029, increasing from US$ 82150 million in 2022, with the CAGR of 10.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Metabolic Disorders Treatment market research.

The Metabolic Disorders Drugs market refers to the pharmaceuticals and medications used for the treatment of disorders related to metabolism, such as diabetes, obesity, hyperlipidemia, and thyroid disorders. This market encompasses various therapeutic areas including antidiabetic drugs, lipid-lowering agents, and thyroid hormone replacements. The Metabolic Disorders Drugs market has been experiencing significant growth due to factors such as the increasing prevalence of metabolic disorders globally, sedentary lifestyles, and unhealthy dietary habits. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America currently holds a significant market share, followed by Europe. However, the market in Asia Pacific is expected to witness substantial growth in the coming years, driven by the rising incidence of metabolic disorders and improving healthcare infrastructure.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Metabolic Disorders Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
    Merck
    Novartis
    Takeda Pharmaceutical
    Astra Zeneca
    Boehringer Ingelheim
    KOWA
    Kythera
    Fuji yakuhin
    LG Life Science
    Metsubishi Tanabe Pharma

Segment by Type
    Glycogen Metabolism Disease Drug
    Lipid Metabolism Disease Drug
    Amino Acid Metabolism Drug
    Other

Segment by Application
    Hospital
    Retail Pharmacy

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

The Metabolic Disorders Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

undefined

Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Metabolic Disorders Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Glycogen Metabolism Disease Drug
        1.2.3 Lipid Metabolism Disease Drug
        1.2.4 Amino Acid Metabolism Drug
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Metabolic Disorders Treatment Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospital
        1.3.3 Retail Pharmacy
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

2 Global Growth Trends
    2.1 Global Metabolic Disorders Treatment Market Perspective (2018-2029)
    2.2 Metabolic Disorders Treatment Growth Trends by Region
        2.2.1 Global Metabolic Disorders Treatment Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Metabolic Disorders Treatment Historic Market Size by Region (2018-2023)
        2.2.3 Metabolic Disorders Treatment Forecasted Market Size by Region (2024-2029)
    2.3 Metabolic Disorders Treatment Market Dynamics
        2.3.1 Metabolic Disorders Treatment Industry Trends
        2.3.2 Metabolic Disorders Treatment Market Drivers
        2.3.3 Metabolic Disorders Treatment Market Challenges
        2.3.4 Metabolic Disorders Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Metabolic Disorders Treatment Players by Revenue
        3.1.1 Global Top Metabolic Disorders Treatment Players by Revenue (2018-2023)
        3.1.2 Global Metabolic Disorders Treatment Revenue Market Share by Players (2018-2023)
    3.2 Global Metabolic Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Metabolic Disorders Treatment Revenue
    3.4 Global Metabolic Disorders Treatment Market Concentration Ratio
        3.4.1 Global Metabolic Disorders Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Metabolic Disorders Treatment Revenue in 2022
    3.5 Metabolic Disorders Treatment Key Players Head office and Area Served
    3.6 Key Players Metabolic Disorders Treatment Product Solution and Service
    3.7 Date of Enter into Metabolic Disorders Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Metabolic Disorders Treatment Breakdown Data by Type
    4.1 Global Metabolic Disorders Treatment Historic Market Size by Type (2018-2023)
    4.2 Global Metabolic Disorders Treatment Forecasted Market Size by Type (2024-2029)

5 Metabolic Disorders Treatment Breakdown Data by Application
    5.1 Global Metabolic Disorders Treatment Historic Market Size by Application (2018-2023)
    5.2 Global Metabolic Disorders Treatment Forecasted Market Size by Application (2024-2029)

6 North America
    6.1 North America Metabolic Disorders Treatment Market Size (2018-2029)
    6.2 North America Metabolic Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Metabolic Disorders Treatment Market Size by Country (2018-2023)
    6.4 North America Metabolic Disorders Treatment Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada

7 Europe
    7.1 Europe Metabolic Disorders Treatment Market Size (2018-2029)
    7.2 Europe Metabolic Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Metabolic Disorders Treatment Market Size by Country (2018-2023)
    7.4 Europe Metabolic Disorders Treatment Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

8 Asia-Pacific
    8.1 Asia-Pacific Metabolic Disorders Treatment Market Size (2018-2029)
    8.2 Asia-Pacific Metabolic Disorders Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Metabolic Disorders Treatment Market Size by Region (2018-2023)
    8.4 Asia-Pacific Metabolic Disorders Treatment Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

9 Latin America
    9.1 Latin America Metabolic Disorders Treatment Market Size (2018-2029)
    9.2 Latin America Metabolic Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Metabolic Disorders Treatment Market Size by Country (2018-2023)
    9.4 Latin America Metabolic Disorders Treatment Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Metabolic Disorders Treatment Market Size (2018-2029)
    10.2 Middle East & Africa Metabolic Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Metabolic Disorders Treatment Market Size by Country (2018-2023)
    10.4 Middle East & Africa Metabolic Disorders Treatment Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Detail
        11.1.2 Merck Business Overview
        11.1.3 Merck Metabolic Disorders Treatment Introduction
        11.1.4 Merck Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.1.5 Merck Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Detail
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Metabolic Disorders Treatment Introduction
        11.2.4 Novartis Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.2.5 Novartis Recent Development
    11.3 Takeda Pharmaceutical
        11.3.1 Takeda Pharmaceutical Company Detail
        11.3.2 Takeda Pharmaceutical Business Overview
        11.3.3 Takeda Pharmaceutical Metabolic Disorders Treatment Introduction
        11.3.4 Takeda Pharmaceutical Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.3.5 Takeda Pharmaceutical Recent Development
    11.4 Astra Zeneca
        11.4.1 Astra Zeneca Company Detail
        11.4.2 Astra Zeneca Business Overview
        11.4.3 Astra Zeneca Metabolic Disorders Treatment Introduction
        11.4.4 Astra Zeneca Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.4.5 Astra Zeneca Recent Development
    11.5 Boehringer Ingelheim
        11.5.1 Boehringer Ingelheim Company Detail
        11.5.2 Boehringer Ingelheim Business Overview
        11.5.3 Boehringer Ingelheim Metabolic Disorders Treatment Introduction
        11.5.4 Boehringer Ingelheim Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.5.5 Boehringer Ingelheim Recent Development
    11.6 KOWA
        11.6.1 KOWA Company Detail
        11.6.2 KOWA Business Overview
        11.6.3 KOWA Metabolic Disorders Treatment Introduction
        11.6.4 KOWA Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.6.5 KOWA Recent Development
    11.7 Kythera
        11.7.1 Kythera Company Detail
        11.7.2 Kythera Business Overview
        11.7.3 Kythera Metabolic Disorders Treatment Introduction
        11.7.4 Kythera Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.7.5 Kythera Recent Development
    11.8 Fuji yakuhin
        11.8.1 Fuji yakuhin Company Detail
        11.8.2 Fuji yakuhin Business Overview
        11.8.3 Fuji yakuhin Metabolic Disorders Treatment Introduction
        11.8.4 Fuji yakuhin Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.8.5 Fuji yakuhin Recent Development
    11.9 LG Life Science
        11.9.1 LG Life Science Company Detail
        11.9.2 LG Life Science Business Overview
        11.9.3 LG Life Science Metabolic Disorders Treatment Introduction
        11.9.4 LG Life Science Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.9.5 LG Life Science Recent Development
    11.10 Metsubishi Tanabe Pharma
        11.10.1 Metsubishi Tanabe Pharma Company Detail
        11.10.2 Metsubishi Tanabe Pharma Business Overview
        11.10.3 Metsubishi Tanabe Pharma Metabolic Disorders Treatment Introduction
        11.10.4 Metsubishi Tanabe Pharma Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.10.5 Metsubishi Tanabe Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Table of Figures

List of Tables
    Table 1. Global Metabolic Disorders Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Glycogen Metabolism Disease Drug
    Table 3. Key Players of Lipid Metabolism Disease Drug
    Table 4. Key Players of Amino Acid Metabolism Drug
    Table 5. Key Players of Other
    Table 6. Global Metabolic Disorders Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Metabolic Disorders Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 8. Global Metabolic Disorders Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 9. Global Metabolic Disorders Treatment Market Share by Region (2018-2023)
    Table 10. Global Metabolic Disorders Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 11. Global Metabolic Disorders Treatment Market Share by Region (2024-2029)
    Table 12. Metabolic Disorders Treatment Market Trends
    Table 13. Metabolic Disorders Treatment Market Drivers
    Table 14. Metabolic Disorders Treatment Market Challenges
    Table 15. Metabolic Disorders Treatment Market Restraints
    Table 16. Global Metabolic Disorders Treatment Revenue by Players (2018-2023) & (US$ Million)
    Table 17. Global Metabolic Disorders Treatment Market Share by Players (2018-2023)
    Table 18. Global Top Metabolic Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Disorders Treatment as of 2022)
    Table 19. Ranking of Global Top Metabolic Disorders Treatment Companies by Revenue (US$ Million) in 2022
    Table 20. Global 5 Largest Players Market Share by Metabolic Disorders Treatment Revenue (CR5 and HHI) & (2018-2023)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Metabolic Disorders Treatment Product Solution and Service
    Table 23. Date of Enter into Metabolic Disorders Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Metabolic Disorders Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Global Metabolic Disorders Treatment Revenue Market Share by Type (2018-2023)
    Table 27. Global Metabolic Disorders Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 28. Global Metabolic Disorders Treatment Revenue Market Share by Type (2024-2029)
    Table 29. Global Metabolic Disorders Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 30. Global Metabolic Disorders Treatment Revenue Market Share by Application (2018-2023)
    Table 31. Global Metabolic Disorders Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 32. Global Metabolic Disorders Treatment Revenue Market Share by Application (2024-2029)
    Table 33. North America Metabolic Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 34. North America Metabolic Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 35. North America Metabolic Disorders Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 36. Europe Metabolic Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. Europe Metabolic Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 38. Europe Metabolic Disorders Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 39. Asia-Pacific Metabolic Disorders Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 40. Asia-Pacific Metabolic Disorders Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 41. Asia-Pacific Metabolic Disorders Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 42. Latin America Metabolic Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. Latin America Metabolic Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Metabolic Disorders Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Metabolic Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 46. Middle East & Africa Metabolic Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 47. Middle East & Africa Metabolic Disorders Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 48. Merck Company Detail
    Table 49. Merck Business Overview
    Table 50. Merck Metabolic Disorders Treatment Product
    Table 51. Merck Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 52. Merck Recent Development
    Table 53. Novartis Company Detail
    Table 54. Novartis Business Overview
    Table 55. Novartis Metabolic Disorders Treatment Product
    Table 56. Novartis Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 57. Novartis Recent Development
    Table 58. Takeda Pharmaceutical Company Detail
    Table 59. Takeda Pharmaceutical Business Overview
    Table 60. Takeda Pharmaceutical Metabolic Disorders Treatment Product
    Table 61. Takeda Pharmaceutical Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 62. Takeda Pharmaceutical Recent Development
    Table 63. Astra Zeneca Company Detail
    Table 64. Astra Zeneca Business Overview
    Table 65. Astra Zeneca Metabolic Disorders Treatment Product
    Table 66. Astra Zeneca Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 67. Astra Zeneca Recent Development
    Table 68. Boehringer Ingelheim Company Detail
    Table 69. Boehringer Ingelheim Business Overview
    Table 70. Boehringer Ingelheim Metabolic Disorders Treatment Product
    Table 71. Boehringer Ingelheim Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 72. Boehringer Ingelheim Recent Development
    Table 73. KOWA Company Detail
    Table 74. KOWA Business Overview
    Table 75. KOWA Metabolic Disorders Treatment Product
    Table 76. KOWA Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 77. KOWA Recent Development
    Table 78. Kythera Company Detail
    Table 79. Kythera Business Overview
    Table 80. Kythera Metabolic Disorders Treatment Product
    Table 81. Kythera Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 82. Kythera Recent Development
    Table 83. Fuji yakuhin Company Detail
    Table 84. Fuji yakuhin Business Overview
    Table 85. Fuji yakuhin Metabolic Disorders Treatment Product
    Table 86. Fuji yakuhin Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 87. Fuji yakuhin Recent Development
    Table 88. LG Life Science Company Detail
    Table 89. LG Life Science Business Overview
    Table 90. LG Life Science Metabolic Disorders Treatment Product
    Table 91. LG Life Science Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 92. LG Life Science Recent Development
    Table 93. Metsubishi Tanabe Pharma Company Detail
    Table 94. Metsubishi Tanabe Pharma Business Overview
    Table 95. Metsubishi Tanabe Pharma Metabolic Disorders Treatment Product
    Table 96. Metsubishi Tanabe Pharma Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 97. Metsubishi Tanabe Pharma Recent Development
    Table 98. Research Programs/Design for This Report
    Table 99. Key Data Information from Secondary Sources
    Table 100. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Metabolic Disorders Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Metabolic Disorders Treatment Market Share by Type: 2022 VS 2029
    Figure 3. Glycogen Metabolism Disease Drug Features
    Figure 4. Lipid Metabolism Disease Drug Features
    Figure 5. Amino Acid Metabolism Drug Features
    Figure 6. Other Features
    Figure 7. Global Metabolic Disorders Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 8. Global Metabolic Disorders Treatment Market Share by Application: 2022 VS 2029
    Figure 9. Hospital Case Studies
    Figure 10. Retail Pharmacy Case Studies
    Figure 11. Metabolic Disorders Treatment Report Years Considered
    Figure 12. Global Metabolic Disorders Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 13. Global Metabolic Disorders Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Metabolic Disorders Treatment Market Share by Region: 2022 VS 2029
    Figure 15. Global Metabolic Disorders Treatment Market Share by Players in 2022
    Figure 16. Global Top Metabolic Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Disorders Treatment as of 2022)
    Figure 17. The Top 10 and 5 Players Market Share by Metabolic Disorders Treatment Revenue in 2022
    Figure 18. North America Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 19. North America Metabolic Disorders Treatment Market Share by Country (2018-2029)
    Figure 20. United States Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Canada Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Metabolic Disorders Treatment Market Share by Country (2018-2029)
    Figure 24. Germany Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. France Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. U.K. Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Italy Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Russia Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Nordic Countries Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Asia-Pacific Metabolic Disorders Treatment Market Share by Region (2018-2029)
    Figure 32. China Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Japan Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. South Korea Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Southeast Asia Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. India Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Australia Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Latin America Metabolic Disorders Treatment Market Share by Country (2018-2029)
    Figure 40. Mexico Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Brazil Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Middle East & Africa Metabolic Disorders Treatment Market Share by Country (2018-2029)
    Figure 44. Turkey Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Saudi Arabia Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Merck Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 47. Novartis Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 48. Takeda Pharmaceutical Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 49. Astra Zeneca Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 50. Boehringer Ingelheim Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 51. KOWA Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 52. Kythera Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 53. Fuji yakuhin Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 54. LG Life Science Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 55. Metsubishi Tanabe Pharma Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed

Description

Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc.

According to QYResearch’s new survey, global Metabolic Disorders Treatment market is projected to reach US$ 160970 million in 2029, increasing from US$ 82150 million in 2022, with the CAGR of 10.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Metabolic Disorders Treatment market research.

The Metabolic Disorders Drugs market refers to the pharmaceuticals and medications used for the treatment of disorders related to metabolism, such as diabetes, obesity, hyperlipidemia, and thyroid disorders. This market encompasses various therapeutic areas including antidiabetic drugs, lipid-lowering agents, and thyroid hormone replacements. The Metabolic Disorders Drugs market has been experiencing significant growth due to factors such as the increasing prevalence of metabolic disorders globally, sedentary lifestyles, and unhealthy dietary habits. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America currently holds a significant market share, followed by Europe. However, the market in Asia Pacific is expected to witness substantial growth in the coming years, driven by the rising incidence of metabolic disorders and improving healthcare infrastructure.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Metabolic Disorders Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
    Merck
    Novartis
    Takeda Pharmaceutical
    Astra Zeneca
    Boehringer Ingelheim
    KOWA
    Kythera
    Fuji yakuhin
    LG Life Science
    Metsubishi Tanabe Pharma

Segment by Type
    Glycogen Metabolism Disease Drug
    Lipid Metabolism Disease Drug
    Amino Acid Metabolism Drug
    Other

Segment by Application
    Hospital
    Retail Pharmacy

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

The Metabolic Disorders Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

undefined

Related Reports

Global Metabolic Disorders Treatment Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2023-05-30
Pages: 107
USD 5600.00
(Single User License)
Global Metabolic Disorders Treatment Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2023-07-25
Pages: 104
USD 3350.00
(Single User License)
Global Metabolic Disorders Treatment Market Insights, Forecast to 2029
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2023-08-28
Pages: 105
USD 4900.00
(Single User License)
Metabolic Disorders Treatment - Global Market Insights and Sales Trends 2024
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2023-11-15
Pages: 102
USD 3350.00
(Single User License)
Global Metabolic Disorders Treatment Market Research Report 2024
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2024-01-05
Pages: 87
USD 2900.00
(Single User License)
Metabolic Disorders Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2024-01-24
Pages: 115
USD 3950.00
(Single User License)
Global Metabolic Disorders Treatment Market Insights, Forecast to 2030
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2024-04-25
Pages: 105
USD 4900.00
(Single User License)
Global Metabolic Disorders Treatment Market Research Report 2025
The global market for Metabolic Disorders Treatment was valued at US$ 98580 million in the year 2024
Published: 2025-02-27
Pages: 76
USD 2900.00
(Single User License)
Metabolic Disorders Treatment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Metabolic Disorders Treatment was estimated to be worth US$ 98580 million in 2
Published: 2025-02-27
Pages: 98
USD 3950.00
(Single User License)